Parabricks

Parabricks is a bioinformatics software company that specializes in high-performance computing solutions for genomic analysis. Founded as a startup out of the University of Michigan, the company developed a suite of tools that leverage GPU acceleration to significantly speed up the processing of next-generation sequencing (NGS) data. Their core technology allows for the rapid execution of standard pipelines like GATK, reducing analysis time from days to minutes while maintaining high accuracy. Following its acquisition by NVIDIA in 2019, the technology was integrated into the NVIDIA Clara healthcare platform as Clara Parabricks. The software is widely used by clinical labs, research institutions, and pharmaceutical companies to scale their genomic workflows and support precision medicine initiatives. It provides a comprehensive environment for secondary analysis, including germline, somatic, and RNA-seq workflows.